RT Journal Article
SR Electronic
A1 Buckley, Rita
T1 Ceftolozane/Tazobactam Safe and Effective Against Complicated UTIs and Pyelonephritis
JF MD Conference Express
YR 2015
FD SAGE Publications
VO 15
IS 48
SP 17
OP 18
DO 10.1177/1559897715590978
UL http://mdc.sagepub.com/content/15/48/17.abstract
AB A novel antibacterial agent, ceftolozane/tazobactam, compared with levofloxacin had higher rates of microbiological eradication in patients with hospital-acquired complicated urinary tract infections, including pyelonephritis, with a good safety profile, according to results of a European substudy of the ASPECT-cUTI study. The novel agent was more effective against 4 of the 5 most frequent pathogens and against drug-resistant pathogens.